Disease: Episodic Cluster Headache ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0393739
Disease: Episodic Cluster Headache
Episodic Cluster Headache 		0.020 Biomarker disease BEFREE The ACute Treatment of Cluster Headache Studies (ACT1 and ACT2), both double-blind sham-controlled randomized trials, did not meet the primary endpoints of the trials but each demonstrated significant superiority of gammaCore among patients with eCH. 29144717 2017
CUI: C0393739
Disease: Episodic Cluster Headache
Episodic Cluster Headache 		0.020 Biomarker disease BEFREE The economic burden of episodic cluster headache is considerable, costing more than twice that of nonheadache patients. gammaCore adjunct to standard of care (SoC) was found to have superior efficacy in treatment of acute episodic cluster headaches compared with sham-gammaCore used with SoC in ACT1 and ACT2 trials. 29144720 2017